HR 1193 · 117th Congress 2021–2023, ended

Cardiovascular Advances in Research and Opportunities Legacy Act

Latest action · Dec 20, 2022 Became Public Law No: 117-244.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedFeb 22, 2021
  2. Passed HouseDec 8, 2021
  3. Passed SenateDec 1, 2022
  4. To the PresidentDec 16, 2022
  5. Became lawDec 20, 2022Public Law 117-244

Summary

Cardiovascular Advances in Research and Opportunities Legacy Act

This act addresses research, education, and awareness concerning valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart.

The National Institutes of Health may conduct or support research on the disease in consultation with the National Heart, Lung, and Blood Institute (NHLBI). The NHLBI must also conduct a workshop on mitral valve prolapse, which occurs when the valve between the chambers of the left side of the heart seals improperly.

The Department of Health and Human Services (HHS) must develop best practices to treat valvular heart disease. HHS may also carry out other projects to increase education and awareness of the disease.

Cosponsors 183

Members who signed on, in the order they did. Signatures ran from Feb 23, 2021 to Dec 8, 2021.

SeatCosponsorSigned on
D-NYKathleen M. RiceFeb 23, 2021
R-GAA. Drew Ferguson IVFeb 24, 2021
R-MOAnn WagnerFeb 24, 2021
R-GAAustin ScottFeb 24, 2021
R-GABarry LoudermilkFeb 24, 2021
R-MIBill HuizengaFeb 24, 2021
R-KYBrett GuthrieFeb 24, 2021
R-PABrian K. FitzpatrickFeb 24, 2021
R-NJChristopher H. SmithFeb 24, 2021
R-NYClaudia TenneyFeb 24, 2021
R-WADan NewhouseFeb 24, 2021
R-OHDavid P. JoyceFeb 24, 2021
D-WADerek KilmerFeb 24, 2021
R-NCGregory F. MurphyFeb 24, 2021
D-NYGregory W. MeeksFeb 24, 2021

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Feb 22, 2021Markup Nov 17, 2021Reported Dec 8, 2021
Health Subcommittee
Referred Feb 23, 2021Markup Nov 4, 2021Reported Nov 4, 2021
SenateHealth, Education, Labor, and Pensions Committee
Referred May 25, 2022Markup Jun 14, 2022Reported Jul 12, 2022

Actions 31

Everything that happened, newest first.

  1. Dec 20, 2022Signed by President.
  2. Dec 20, 2022Became Public Law No: 117-244.
  3. Dec 16, 2022Presented to President.
  4. Dec 5, 2022Message on Senate action sent to the House.
  5. Dec 5, 2022Mr. Pallone moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H8755-8756)
  6. Dec 5, 2022DEBATE - The House proceeded with forty minutes of debate on the Senate amendment to H.R. 1193.
  7. Dec 5, 2022Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote. (text: CR H8755)
  8. Dec 5, 2022Motion to reconsider laid on the table Agreed to without objection.
  9. Dec 1, 2022Measure laid before Senate by unanimous consent. (consideration: CR S6946-6947)
  10. Dec 1, 2022The committee substitute withdrawn by Unanimous Consent.
  11. Dec 1, 2022Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S6947)
  12. Jul 12, 2022Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.
  13. Jul 12, 2022Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.
  14. Jun 14, 2022Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
  15. May 25, 2022Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  16. Dec 9, 2021Received in the Senate.
  17. Dec 8, 2021Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-212.
  18. Dec 8, 2021Placed on the Union Calendar, Calendar No. 153.
  19. Dec 8, 2021Mr. Pallone moved to suspend the rules and pass the bill, as amended.
  20. Dec 8, 2021Considered under suspension of the rules. (consideration: CR H7518-7522)
  21. Dec 8, 2021DEBATE - The House proceeded with forty minutes of debate on H.R. 1193.
  22. Dec 8, 2021Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7518)
  23. Dec 8, 2021Motion to reconsider laid on the table Agreed to without objection.
  24. Dec 8, 2021The title of the measure was amended. Agreed to without objection.
  25. Nov 17, 2021Committee Consideration and Mark-up Session Held.
  26. Nov 17, 2021Ordered to be Reported (Amended) by Voice Vote.
  27. Nov 4, 2021Subcommittee Consideration and Mark-up Session Held.
  28. Nov 4, 2021Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
  29. Feb 23, 2021Referred to the Subcommittee on Health.
  30. Feb 22, 2021Introduced in House
  31. Feb 22, 2021Referred to the House Committee on Energy and Commerce.

In the Congressional Record 3

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
House · SenateDebate and remarks H8755, H8756, S6950Amendments H8755Andy Barr R-KY, Frank Pallone, Jr. D-NJ, John Joyce R-PA, Mitch McConnell R-KYDec 5, 2022
SenateDebate and remarks S6946, S6947Text printed S6947Amendments S6945, S6946, S6947Angus S. King Jr. I-ME, Mitch McConnell R-KY (amendment)Dec 1, 2022
House · ExtensionsDebate and remarks E1342, H7518–H7522Text printed H7518Andy Barr R-KY, Anna G. Eshoo D-CA, Bill Huizenga R-MI, Brad R. Wenstrup R-OH, Brett Guthrie R-KY, Cathy McMorris Rodgers R-WA, Frank Pallone, Jr. D-NJ, Jimmy Panetta D-CA, Kathleen M. Rice D-NY, Kevin McCarthy R-CA, Steve Scalise R-LADec 8, 2021

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 18: ``The Congress shall have power to . . . make all laws which shall be necessary and proper for carrying into Execution the foregoing Powers . . . in the Government of the United States, or in any Department or Officer thereof''

The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 33, February 22, 2021, page H549.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 117-53ENHANCING PUBLIC HEALTH: LEGISLATION TO PROTECT CHILDREN AND FAMILIES239 pagesEnergy and Commerce CommitteeOct 20, 2021

Amendments 1

Amendments offered to this bill.

AmendmentDescriptionOffered byStatus
SA 6504In the nature of a substitute.Mitch McConnell R-KYAmendment SA 6504 agreed to in Senate by Unanimous Consent.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 1133Cardiovascular Advances in Research and Opportunities Legacy ActRelated billApr 15, 2021

Titles 11

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title IV of the Public Health Service Act to direct the Director of the National Institutes of Health, in consultation with the Director of the National Heart, Lung, and Blood Institute, shall establish a program under which the Director of the National Institutes of Health shall support or conduct research on valvular heart disease, and for other purposes.
Official Titles as Amended by House
To amend title IV of the Public Health Service Act to direct the Director of the National Institutes of Health, in consultation with the Director of the National Heart, Lung, and Blood Institute, to establish a program under which the Director of the National Institutes of Health shall support or conduct research on valvular heart disease, and for other purposes.
Short Titles as Passed Senate
Cardiovascular Advances in Research and Opportunities Legacy Act
Short Titles as Enacted
Cardiovascular Advances in Research and Opportunities Legacy Act
Short Title(s) as Introduced
Cardiovascular Advances in Research and Opportunities Legacy Act
Short Title(s) as Reported to House
Cardiovascular Advances in Research and Opportunities Legacy Act
Short Title(s) as Reported to Senate
Cardiovascular Advances in Research and Opportunities Legacy Act
Short Title(s) as Passed House
Cardiovascular Advances in Research and Opportunities Legacy Act
Short Titles from ENR (Enrolled) bill text
Cardiovascular Advances in Research and Opportunities Legacy Act
Short Title(s) from Engrossed Amendment Senate bill text
Cardiovascular Advances in Research and Opportunities Legacy Act
Short Titles from RFS (Referred to Senate) bill text
Cardiovascular Advances in Research and Opportunities Legacy Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 8

Each version as it was printed, newest first.

  1. —Enrolled Bill
  2. Dec 1, 2022Engrossed Amendment Senate
  3. Jul 12, 2022Reported to Senate
  4. May 25, 2022Referred in Senate
  5. Dec 9, 2021Received in Senate
  6. Dec 8, 2021Reported in House
  7. Dec 8, 2021Engrossed in House
  8. Feb 22, 2021Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.